Eric Falcone

Title: Eric Falcone: Innovator in Pharmaceutical Compositions

Introduction

Eric Falcone is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of bone mineralization disorders. His work is characterized by a focus on innovative solutions that address critical health issues.

Latest Patents

Eric Falcone holds a patent for "Alkaline phosphatase polypeptides and methods of use thereof." This patent features pharmaceutical compositions that include a soluble alkaline phosphatase for treating bone mineralization disorders, such as hypophosphatasia (HPP), and symptoms thereof. The polypeptides include a soluble alkaline phosphatase (sALP) or fragment thereof, which is derived from a naturally occurring alkaline phosphatase (ALP). He has 1 patent to his name.

Career Highlights

Eric is currently employed at Alexion Pharmaceuticals, Inc., where he continues to develop innovative treatments. His work at Alexion has positioned him as a key player in the pharmaceutical industry, contributing to advancements in medical science.

Collaborations

Eric has collaborated with notable colleagues, including Walter C Voegtli and Yuhong Wu. These partnerships have enhanced his research and development efforts, leading to impactful innovations in the field.

Conclusion

Eric Falcone's contributions to pharmaceutical compositions demonstrate his commitment to improving health outcomes through innovation. His work continues to inspire advancements in the treatment of bone mineralization disorders.